Angiotensin II relaxes microvessels via the AT2 receptor and Ca2+-activated K+ (BKCa) channels

被引:85
作者
Dimitropoulou, C
White, RE
Fuchs, L
Zhang, HF
Catravas, JD
Carrier, GO
机构
[1] Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA
[2] Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA
关键词
angiotensin II; receptors; angiotensin; potassium channels; patch-clamp techniques;
D O I
10.1161/01.HYP.37.2.301
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Angiotensin II (Ang II) is one of the most potent vasoconstrictor substances, yet paradoxically, Ang II may dilate certain vascular beds via an undefined mechanism. Ang II-induced vasoconstriction is mediated by the AT(1) receptor, whereas the relative expression and functional importance of the AT(2) receptor in regulating vascular resistance and blood pressure are unknown. We now report that Ang II induces relaxation of mesenteric microvessels and that this vasodilatory response was unaffected by losartan, an AT(1) receptor antagonist, but was inhibited by PD123,319, a selective antagonist of AT(2) receptors. In addition, reverse transcriptase-polymerase chain reaction studies revealed high amounts of AT(2) receptor mRNA in smooth muscle from these same microvessels. Ang II-induced relaxation was inhibited by either tetraethylammonium or iberiotoxin, suggesting involvement of the large-conductance, calcium- and voltage-activated potassium (BKCa) channel. Subsequent whole-cell and single-channel patch-clamp studies on single myocytes demonstrated that Ang II increases the activity of BKCa channels. As in our tissue studies, the effect of Ang II on BKCa channels was inhibited by PD123,319, but not by losartan. In light of these consistent findings from tissue physiology, molecular studies, and cellular/molecular physiology, we conclude that Ang II relaxes microvessels via stimulation of the AT(2) receptor with subsequent opening of BKCa channels, leading to membrane repolarization and vasodilation. These findings provide evidence for a novel endothelium-independent vasodilatory effect of Ang II.
引用
收藏
页码:301 / 307
页数:7
相关论文
共 27 条
[1]   Increased vasoconstrictor response of the mouse lacking angiotensin II type 2 receptor [J].
Akishita, M ;
Yamada, H ;
Dzau, VJ ;
Horiuchi, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 261 (02) :345-349
[2]   Possible role of P-450 metabolite of arachidonic acid in vasodilator mechanism of angiotensin II type 2 receptor in the isolated microperfused rabbit afferent arteriole [J].
Arima, S ;
Endo, Y ;
Yaoita, H ;
Omata, K ;
Ogawa, S ;
Tsunoda, K ;
Abe, M ;
Takeuchi, K ;
Abe, K ;
Ito, S .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (11) :2816-2823
[3]   H2O2 opens BKCa channels via the PLA2-arachidonic acid signaling cascade in coronary artery smooth muscle [J].
Barlow, RS ;
El-Mowafy, AM ;
White, RE .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2000, 279 (02) :H475-H483
[4]   Nitrovasodilators relax mesenteric microvessels by cGMP-induced stimulation of Ca-activated K channels [J].
Carrier, GO ;
Fuchs, LC ;
Winecoff, AP ;
Giulumian, AD ;
White, RE .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1997, 273 (01) :H76-H84
[5]   OUTWARD CURRENTS IN RABBIT PULMONARY-ARTERY CELLS DISSOCIATED WITH A NEW TECHNIQUE [J].
CLAPP, LH ;
GURNEY, AM .
EXPERIMENTAL PHYSIOLOGY, 1991, 76 (05) :677-693
[6]   The AT2 receptor:: fact, fancy and fantasy [J].
de Gasparo, M ;
Siragy, HM .
REGULATORY PEPTIDES, 1999, 81 (1-3) :11-24
[7]   ANGIOTENSIN-II INDUCES ENDOTHELIUM-DEPENDENT VASODILATION OF RAT CEREBRAL ARTERIOLES [J].
HABERL, RL ;
ANNESER, F ;
VILLRINGER, A ;
EINHAUPL, KM .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 258 (06) :H1840-H1846
[8]   ANGIOTENSIN DEGRADATION PRODUCTS MEDIATE ENDOTHELIUM-DEPENDENT DILATION OF RABBIT BRAIN ARTERIOLES [J].
HABERL, RL ;
DECKER, PJ ;
EINHAUPL, KM .
CIRCULATION RESEARCH, 1991, 68 (06) :1621-1627
[9]   A novel transduction mechanism mediating dopamine-induced vascular relaxation;: Opening of BKCa channels by cyclic AMP-induced stimulation of the cyclic GMP-dependent protein kinase [J].
Han, GC ;
Kryman, JP ;
McMillin, PJP ;
White, RE ;
Carrier, GO .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1999, 34 (05) :619-627
[10]  
Hubner R, 1997, J HUM HYPERTENS, V11, pS19